Rheumatoid Arthritis

Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases

Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases

By

Rheuatology Advisor speaks with a psychologist about addressing mental health in patients with inflammatory arthritis.

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

By

In patients with rheumatoid arthritis or osteoarthritis who are at higher risk for cardiovascular events, celecoxib may be safer compared with naproxen or ibuprofen when these drugs are taken alone or in combination with aspirin.

Expert Q&A: Effects of Collaborative Care Models on Patient Satisfaction in Rheumatoid Arthritis

Expert Q&A: Effects of Collaborative Care Models on Patient Satisfaction in Rheumatoid Arthritis

By

John M. Davis III, MD, MS, from the Mayo Clinic in Rochester, Minnesota, and Jennifer Gorman, MD, MPH, from The Polyclinic in Seattle, Washington, discuss the evolving collaborative care therapy model in RA.

GI Safety Compared for NSAIDs in Patients With Arthritis

GI Safety Compared for NSAIDs in Patients With Arthritis

By

The randomized, double-blind, controlled trial (N=24,081) included patients with rheumatoid arthritis or osteoarthritis who required chronic NSAID treatment.

Quality of Life in Rheumatoid Arthritis Improved With Filgotinib

Quality of Life in Rheumatoid Arthritis Improved With Filgotinib

By

The results of 2 randomized controlled trials showed that filgotinib improved quality of life when given in combination with methotrexate or as monotherapy in rheumatoid arthritis.

Incidence of Musculoskeletal Disorders, Depression in Migraine

Incidence of Musculoskeletal Disorders, Depression in Migraine

By

Fibromyalgia, osteoarthritis, sciatic syndrome, rheumatoid arthritis, and moderate depression may be more prevalent in working-age individuals with vs without migraine.

Radiofrequency Ablation for Chronic Hip Pain: Reviewing the Evidence

Radiofrequency Ablation for Chronic Hip Pain: Reviewing the Evidence

By

The available evidence suggests that radiofrequency ablation is a feasible treatment option for chronic hip pain associated with degenerative diseases.

Guidelines for Biosimilar Use for Treatment of Rheumatologic Diseases

Guidelines for Biosimilar Use for Treatment of Rheumatologic Diseases

By

Consensus recommendations on the use of biosimilars for the treatment of patients with rheumatologic diseases were recently published in Annals of the Rheumatic Diseases.

Ketoprofen Safe, Effective Pain Management for Rheumatoid Arthritis

Ketoprofen Safe, Effective Pain Management for Rheumatoid Arthritis

By

Ketoprofen was found to be effective in relieving moderate to severe pain in patients with rheumatoid arthritis.

Safety Guidelines Issued for Use of RA Drugs During Pregnancy and Lactation

Safety Guidelines Issued for Use of RA Drugs During Pregnancy and Lactation

By

Although a majority of women with rheumatoid arthritis were previously though to achieve remission during pregnancy, recent studies indicate remission occurs in only 20% to 40% of cases.

Vitamin D Deficiency Associated With Neuropathic Pain in Rheumatoid Arthritis

Vitamin D Deficiency Associated With Neuropathic Pain in Rheumatoid Arthritis

By

In patients with rheumatoid arthritis, vitamin D deficiency was shown to be associated with increased neuropathic pain.

Tocilizumab Linked to Anemia Marker Improvement in Rheumatoid Arthritis

Tocilizumab Linked to Anemia Marker Improvement in Rheumatoid Arthritis

By

Tocilizumab was associated with significant improvements in hemoglobin and hematocrit over 2 years of treatment in patients with rheumatoid arthritis.

Rheumatoid Arthritis Flares Effectively Identified With OMERACT Tool

Rheumatoid Arthritis Flares Effectively Identified With OMERACT Tool

By

The lack of a standard definition for disease flare made recognizing them complicated, but it's now easier thanks to a new and effective identification tool from OMERACT.

Morphine Lacks Efficacy for RA, Chronic Fatigue Syndrome and Fibromyalgia

Morphine Lacks Efficacy for RA, Chronic Fatigue Syndrome and Fibromyalgia

For patients with chronic fatigue syndrome/fibromyalgia or rheumatoid arthritis, morphine has anti-hyperalgesic effects comparable with placebo.

Methotrexate Response in RA may be Predicted by Gene Expression

Methotrexate Response in RA may be Predicted by Gene Expression

Increased baseline gene expression in peripheral blood may be associated with improved clinical response to methotrexate in rheumatoid arthritis.

Early CVD Detection in Patients With RA: Expert Insight

Early CVD Detection in Patients With RA: Expert Insight

By

Patients with RA have a significantly higher risk of cardiovascular disease, and cardiac magnetic resonance can help with early diagnosis.

Cardiometabolic and Mortality Risks in Chronic Inflammatory Disorders

Cardiometabolic and Mortality Risks in Chronic Inflammatory Disorders

Certain inflammatory disorders may increase the risk for cardiometabolic events and all-cause mortality.

Disease Activity on Foot MRI Despite Clinical Remission in Rheumatoid Arthritis

Disease Activity on Foot MRI Despite Clinical Remission in Rheumatoid Arthritis

By

A sizeable percentage of patients with rheumatoid arthritis who are in clinical remission have evidence of disease activity on magnetic resonance imaging of the foot that is mostly affected.

Fish Consumption May Reduce RA Symptoms

Fish Consumption May Reduce RA Symptoms

Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis.

Opioid Use Patterns in Rheumatoid Arthritis

Opioid Use Patterns in Rheumatoid Arthritis

By

Longitudinal opioid prescribing patterns suggest that regular use among patients with rheumatoid arthritis (RA) is slightly declining.

Sirukumab Improves Depression in Patients With Rheumatoid Arthritis

Sirukumab Improves Depression in Patients With Rheumatoid Arthritis

By

Peripheral anti-IL-6 cytokine treatment is associated with improvement in depressive symptoms in patients with RA.

Dose-Dependent ACR20 Response Rates in RA With Peficitinib

Dose-Dependent ACR20 Response Rates in RA With Peficitinib

By

Use of the JAK inhibitor peficitinib in combination with certain csDMARDs results in a dose-dependent ACR20 response rate in patients with RA over 12 weeks.

Kevzara Injection Gets FDA Approval for Rheumatoid Arthritis

Kevzara Injection Gets FDA Approval for Rheumatoid Arthritis

By

Regeneron and Sanofi announced that the FDA has approved Kevzara (sarilumab) injection to treat adults with moderate to severe rheumatoid arthritis.

Diagnostic Value of MRI for Unclassified Arthritis

Diagnostic Value of MRI for Unclassified Arthritis

MRI may assist in identifying patients with unclassified arthritis who will develop rheumatoid arthritis (RA) — primarily in patients with UA presenting with oligoarthritis.

Low Disease Activity in Rheumatoid Arthritis After Tofacitinib Discontinuation

Low Disease Activity in Rheumatoid Arthritis After Tofacitinib Discontinuation

By

Approximately 1 in 3 patients with RA who discontinued tofacitinib maintained low disease activity after 1 year.

Ultrasound Remission Not Correlated With Clinical Remission in RA

Ultrasound Remission Not Correlated With Clinical Remission in RA

By

No clear association was found between health status and ultrasound remission in patients with rheumatoid arthritis in clinical remission.

High-Frequency Ultrasound Plus Anti-CCP Testing for Early RA Diagnosis

High-Frequency Ultrasound Plus Anti-CCP Testing for Early RA Diagnosis

By

High-frequency color Doppler ultrasonography combined with anti-cyclic citrullinated peptide antibody testing may allow for earlier diagnosis of rheumatoid arthritis.

Rheumatoid Arthritis Treatment Initiated Early on Shows Good Long-Term Outcomes

Rheumatoid Arthritis Treatment Initiated Early on Shows Good Long-Term Outcomes

By

Patients with RA who were treated in the first 6 months had a lower risk of death.

Testing Patients With Rheumatoid Arthritis for Metabolic Syndrome

Testing Patients With Rheumatoid Arthritis for Metabolic Syndrome

By

A high prevalence and risk for metabolic syndrome was found in patients with rheumatoid arthritis.

Remicade Biosimilar FDA-Approved

Remicade Biosimilar FDA-Approved

By

The FDA has approved Renflexis, the second approved biosimilar to Remicade.

Sign Up for Free e-Newsletters